At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 11 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Pilot Study Examining DCEEG Characteristics in Ketamine Versus Methohexital Induction in Depressed Patients Receiving Electroconvulsive Therapy
In Brief
A Early Phase 1 clinical trial evaluating Ketamine and Methohexital for Electroconvulsive Therapy and 3 related conditions. Completed, enrolled 11 participants across 1 site.
Detailed Summary
The investigators will be examining slow-wave characteristics in depressed patients receiving electroconvulsive therapy (ECT) using direct current electroencephalogram (dcEEG) by anesthesia induction agent.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsElectroconvulsive Therapy, Direct Current Electroencephalogram, Ketamine, Spreadind Depression
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartOct 2019
Primary CompletionOct 2020
TodayJul 2026
First PostedJul 17, 2019
Enrollment StartOct 1, 2019
Primary CompletionOct 1, 2020
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 7.0 years ago
Interventions
Ketaminedrug
Induction agent that suppresses infra-slow waves
Methohexitaldrug
Induction agent that does not suppress infra-slow waves